Journal of Cancer Therapy
Vol.8 No.2(2017), Paper ID 74162, 22
pages
DOI:10.4236/jct.2017.82016
Cyclooxygenase Inhibition in Cancer Immunotherapy: Combination of Indomethacin with Cancer Vaccines Is Not Always Beneficial
Giselle Hevia, Isabel Pablos, Marilyn Clavell, Judith Raymond, Mayrel Labrada, Luis E. Fernández
Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba
Deparment of Molecular Biology, University of Salzburg, Salzburg, Austria
Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba
Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba
Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba
Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba
Copyright © 2017 Giselle Hevia, Isabel Pablos, Marilyn Clavell, Judith Raymond, Mayrel Labrada, Luis E. Fernández et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Hevia, G. , Pablos, I. , Clavell, M. , Raymond, J. , Labrada, M. and Fernández, L. (2017) Cyclooxygenase Inhibition in Cancer Immunotherapy: Combination of Indomethacin with Cancer Vaccines Is Not Always Beneficial.
Journal of Cancer Therapy,
8, 188-209. doi:
10.4236/jct.2017.82016.